Comparison of plasma osteopontin levels between patients with borderline ovarian tumours and serous ovarian carcinoma

Abstract

OPN is a novel biomarker of various cancaers including ovarian carcinoma. OPN is a promising adjunct to a major biomarker of ovarian cancer, CA 125, in diagnosis, differential diagnosis and prognosis

Keywords

• osteopontin
• OPN
• CA 125
• pithelial ovarian cancer
• borderline ovarian tumor